Becton Dickinson and Company - Soft Tissue Core Needle Biopsy and Aspira Unit's Unit Acquisition

Becton Dickinson and Company - Soft Tissue Core Needle Biopsy and Aspira Unit raised a round of funding on February 15, 2018. Investors include Merit Medical Systems.

Becton Dickinson and Company (BD) (NYSE: BDX) is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health nee…

Articles about Becton Dickinson and Company - Soft Tissue Core Needle Biopsy and Aspira Unit's Unit Acquisition: